Welcome!

News Feed Item

Medidata Reports Record Second Quarter 2014 Results

Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced its financial results for the second quarter of 2014 and reiterated its revenue guidance.

“Medidata’s track record of strong growth, profitability and successful innovation gives us great confidence in our future ability to grow and extend our lead in the industry,” said Tarek Sherif, Medidata's chairman and chief executive officer. “Our market opportunity is significant and we are successfully executing on our near- and long-term plan. Reflecting on Medidata’s performance this quarter, we continue to benefit from many of the same positive trends we have seen over the past 18 months, including an improving funding environment for biotechnology companies and increased focus on improving drug development efficiency. We see this reflected in increased deal activity, new customer wins and greater multi-product adoption. Our ability to innovate and expand the breadth and relevance of our platform is fueling greater interest and awareness of our solutions across the globe and is contributing to our growing pipeline of opportunities.”

Second Quarter 2014 Results

  • Total revenues for the second quarter of 2014 were $83.2 million, an increase of $15.1 million, or 22%, compared with $68.1 million in 2013. Subscription revenue was $68.9 million, an increase of 22% compared with the same period last year.
  • GAAP operating income for the quarter was $7.1 million, compared with $8.8 million in the second quarter of 2013. Non-GAAP operating income* for the second quarter of 2014 was $18.4 million, compared with $17.5 million a year ago.
  • GAAP net income for the second quarter of 2014 was $2.3 million, or $0.04 per diluted share, compared with $5.1 million, or $0.09 per diluted share, in the second quarter of 2013. Adjusted non-GAAP net income* for the second quarter of 2014 was $9.4 million, or $0.17 per diluted share, compared with $9.5 million, or $0.18 per diluted share, in the second quarter of 2013. See the non-GAAP reconciliation included in this release for full details of the non-GAAP adjustments.
  • Total cash, cash equivalents and marketable securities were $418.5 million at the end of the second quarter of 2014, an increase of $278.1 million, or 198%, compared with $140.4 million at the end of the second quarter of 2013, primarily due to net proceeds from the convertible senior notes issued during 2013 and strong cash flows over the past year.
  • Cash flow from operations was $24.1 million in the second quarter of 2014, compared with $26.2 million a year ago.

Additional Highlights

  • Medidata’s customer base grew to 437, with 30 new clients added in the second quarter of 2014, an increase of 50% over the number of new clients added in the second quarter of 2013.
  • 54% of customers had committed to multiple products at the end of the second quarter of 2014, up from 45% at the end of the second quarter of 2013.
  • Partners continue to increase their commitments to Medidata for their technology outsourcing, with 2 top CROs signing enterprise deals. Partners also extended their ability to service non-Rave solutions, with accreditations for Medidata Patient Cloud™ as well as other solutions.
  • Billings were $78 million in the second quarter of 2014, a 19% increase over the second quarter of 2013.
  • Subscription backlog for the remainder of the year as of June 30, 2014 increased to $133 million, an increase of $23 million year over year. Remaining subscription backlog does not include revenues associated with intra-year renewals of $2 million.
  • Medidata's overall revenue retention rate was nearly 100%.

“Our strong second quarter results are highlighted by solid, profitable growth, record cash collections and stellar renewal activity,” said Cory Douglas, Medidata’s chief financial officer. “I am particularly pleased with the strength of our execution and disciplined strategic investments in the quarter. Looking ahead, we see an acceleration of subscription revenue growth and record profitability in the second half of the year.”

Financial Outlook

For the full year 2014, the company expects:

  • Revenues between $340.0 and $345.0 million.
  • Professional services revenues in the mid $50.0 million range.
  • Non-GAAP operating income between $80.0 and $83.0 million. Based on current estimates, this would equate to GAAP operating income between $28.5 and $31.5 million.**
  • Adjusted non-GAAP net income, which includes the tax affected adjustments primarily from stock-based compensation, non-cash interest expense associated with convertible senior notes and amortization at a 40% effective tax rate, between $41.0 and $44.0 million. Based on current estimates, this would equate to GAAP net income between $9.0 and $12.0 million.**
  • While changes in the stock price could change the fully diluted share count, the company is assuming 55.1 million fully diluted shares.

**The current estimated GAAP equivalents to our Non-GAAP guidance reflect the impact of approximately $5.0 million on a pre-tax basis of additional stock based compensation expenses relative to our prior outlook.

Conference Call

The company plans to host its investor conference call today at 8:00 a.m. Eastern. The investor conference call will be available via live webcast on the “Investor” section of Medidata’s web site at http://investor.mdsol.com. To participate by telephone, domestic participants may dial 877-303-2528 and international participants may dial 847-829-0023. Those interested in participating in the conference call should dial in at least 10 minutes prior to the call to register. Participants can also join the call via a simultaneous live audio webcast, which will be made available on the “Investor” section of Medidata’s web site at http://investor.mdsol.com. A replay of the conference call can be accessed until Tuesday, August 12, 2014, by dialing 800-585-8367 domestically or 404-537-3406 internationally, with the passcode 72083877. An archive of the call will also be hosted on the “Investor” section of Medidata’s web site, http://investor.mdsol.com, for a limited period of time.

About Medidata

Medidata is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. We are committed to advancing the competitive and scientific goals of global customers, which include over 90% of the top 25 global pharmaceutical companies; innovative biotech, diagnostic and device firms; leading academic medical centers; and contract research organizations.

Cautionary Statement

Certain statements made in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 that involve significant risks and uncertainties about Medidata Solutions, Inc. (“Medidata”), including but not limited to statements about Medidata’s forecast of financial performance, products and services, business model, strategy and growth opportunities, and competitive position. Such statements are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in these statements. In particular, the risks and uncertainties include, among other things, risks associated with possible fluctuations in our financial and operating results; errors, interruptions or delays in our service or our Web hosting; the financial impact of any future acquisitions; our ability to continue to release, and gain customer acceptance of, new and improved versions of our products; changes in our sales and implementation cycles; competition; our ability to retain and expand our customer base or increase new business from those customers; our ability to hire, retain and motivate our employees and manage our growth; regulatory developments; litigation; and general developments in the economy. For additional disclosure regarding these and other risks faced by the company, see disclosures contained in Medidata’s public filings with the Securities and Exchange Commission including, the “Risk Factors” section of Medidata’s Annual Report on Form 10-K for the year ended December 31, 2013. You should consider these factors in evaluating the forward-looking statements included in this press release and not place undue reliance on such statements. The forward-looking statements are made as of the date hereof, and Medidata undertakes no obligation to update such statements as a result of new information.

*Non-GAAP Financial Information

Medidata provides non-GAAP operating income, net income and net income per share applicable to common stockholders data as additional information for its operating results. These measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP measures used by other companies. Non-GAAP operating income excludes the impact of depreciation, amortization of intangible assets associated with acquisitions, stock-based compensation expense, and an adjustment to the fair value of contingent consideration. Adjusted non-GAAP net income excludes the impact of tax-affected amortization of intangible assets associated with acquisitions, stock-based compensation expense, an adjustment to the fair value of contingent consideration, and non-cash interest expense on convertible senior notes. Management uses these non-GAAP measures to evaluate its financial results, develop budgets, manage expenditures, and as an important factor in determining variable compensation. In addition, investors frequently have requested information from management regarding depreciation, amortization and other non-cash charges, such as share-based compensation, and management believes, based on discussions with investors, that these non-GAAP measures enhance investors’ ability to assess Medidata’s historical and projected future financial performance. While management believes these non-GAAP financial measures provide useful supplemental information to investors, there are limitations associated with the use of non-GAAP financial measures. One limitation of non-GAAP operating income is that it excludes depreciation and amortization, which represents the periodic costs of certain capitalized tangible and intangible assets used in generating revenues in our business. Medidata compensates for these limitations by using these non-GAAP financial measures as supplements to GAAP financial measures and by reviewing the reconciliations of the non-GAAP financial measures to their most comparable GAAP financial measures. Investors are encouraged to review the reconciliations of these non-GAAP financial measures to the comparable GAAP results, which are attached to this press release.

       
MEDIDATA SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(Amounts in thousands, except per share data)
Three Months Ended

June 30,

Six Months Ended

June 30,

2014 2013 2014 2013
Revenues
Subscription $ 68,947 $ 56,346 $ 132,758 $ 106,998
Professional services 14,276   11,723   27,105   24,330  
Total revenues 83,223 68,069 159,863 131,328
Cost of revenues (1)(2)
Subscription 11,221 8,949 22,307 17,974
Professional services 9,753   7,971   19,466   16,075  
Total cost of revenues 20,974 16,920 41,773 34,049
Gross profit 62,249 51,149 118,090 97,279
Operating costs and expenses:
Research and development (1) 17,311 12,105 35,100 24,010
Sales and marketing (1)(2) 20,425 16,253 41,157 30,742
General and administrative (1) 17,373   13,955   34,419   26,599  
Total operating costs and expenses 55,109   42,313   110,676   81,351  
Operating income 7,140 8,836 7,414 15,928
Interest and other (expense) income:
Interest expense (3,827 ) (27 ) (7,608 ) (45 )
Interest income 420 59 815 135
Other (expense) income, net (28 ) (10 ) 6   144  
Total interest and other (expense) income, net (3,435 ) 22   (6,787 ) 234  
Income before income taxes 3,705 8,858 627 16,162
Provision for income taxes 1,409   3,752   146   5,356  
Net income $ 2,296   $ 5,106   $ 481   $ 10,806  
Earnings per share:
Basic (3) $ 0.04   $ 0.10   $ 0.01   $ 0.21  
Diluted (3) $ 0.04   $ 0.09   $ 0.01   $ 0.20  
Weighted average common shares outstanding:
Basic (3) 52,457 50,850 52,284 50,546
Diluted (3) 54,828 53,488 54,998 53,056
(1) Stock-based compensation expense included in cost of revenues and operating costs and expenses is as follows:
Cost of revenues $ 1,027 $ 838 $ 2,099 $ 1,325
Research and development 817 627 1,729 1,085
Sales and marketing 1,060 1,722 3,411 2,944
General and administrative 5,726   3,937   11,090   6,975  
Total stock-based compensation $ 8,630   $ 7,124   $ 18,329   $ 12,329  
(2) Amortization expense of intangible assets included in costs of revenues and operating costs and expenses is as follows:
Cost of revenues $ 111 $ 101 $ 219 $ 382
Sales and marketing 30   33   60   146  
Total amortization of intangible assets $ 141   $ 134   $ 279   $ 528  
(3) Prior period results have been adjusted to reflect the two-for-one stock split which was effected in the form of a stock dividend in December 2013.
 

       
MEDIDATA SOLUTIONS, INC.
Reconciliation of GAAP Operating Income and GAAP Net Income to

Non-GAAP Operating Income and Adjusted Non-GAAP Net Income (Unaudited)

(Amounts in thousands, except per share data)
Three Months Ended
June 30,
Six Months Ended
June 30,
2014 2013 2014 2013
Operating income:
GAAP operating income $ 7,140 $ 8,836 $ 7,414 $ 15,928
GAAP operating margins 8.6 % 13.0 % 4.6 % 12.1 %
Stock-based compensation 8,630 7,124 18,329 12,329
Depreciation and amortization 2,609 1,473 5,144 3,324
Contingent consideration adjustment (1)   60     120  
Non-GAAP operating income $ 18,379   $ 17,493   $ 30,887   $ 31,701  
Non-GAAP operating margins 22.1 % 25.7 % 19.3 % 24.1 %
Net income:
GAAP net income $ 2,296 $ 5,106 $ 481 $ 10,806
Stock-based compensation 8,630 7,124 18,329 12,329
Amortization 141 134 279 528
Contingent consideration adjustment (1) 60 120
Non-cash interest expense on convertible senior notes (2) 3,102 6,162
Tax impact on add-back items (3) (4,749 ) (2,927 ) (9,908 ) (5,191 )
Adjusted non-GAAP net income $ 9,420   $ 9,497   $ 15,343   $ 18,592  
GAAP basic earnings per share (4) $ 0.04   $ 0.10   $ 0.01   $ 0.21  
GAAP diluted earnings per share (4) $ 0.04   $ 0.09   $ 0.01   $ 0.20  
Adjusted Non-GAAP basic earnings per share (4) $ 0.18   $ 0.19   $ 0.29   $ 0.37  
Adjusted Non-GAAP diluted earnings per share (4) $ 0.17   $ 0.18   $ 0.28   $ 0.35  
(1) Amount represents the effect of changes in fair value of contingent consideration liability.
(2) During the third quarter of 2013, we issued $287.5 million in convertible senior notes (the "Notes") with a coupon interest rate of 1.00%. Interest is paid semiannually on February 1 and August 1 over the five-year term of the notes. In connection with the Notes, we are required to recognize non-cash interest expense, including amortization of debt discount and issuance costs, in accordance with accounting guidance for convertible debt that may be settled in cash. We exclude this incremental non-cash interest expense for purposes of calculating adjusted non-GAAP net income. We believe that excluding these expenses from our non-GAAP measures is useful to investors because such incremental non-cash interest expense does not generate a cash outflow for the company and the debt issuance costs do not represent a cash outflow for the company except in the period the Notes were issued; therefore both are not indicative of our continuing operations or meaningful when comparing current results to past results.
(3) Tax impact calculated using a 40% tax rate.
(4) Prior period results have been adjusted to reflect the two-for-one stock split which was effected in the form of a stock dividend in December 2013.
 

The table above presents a reconciliation of GAAP to non-GAAP operating income, net income, and net income per share applicable to common stockholders for the three and six months ended June 30, 2014 and 2013. Non-GAAP operating income excludes the impact of depreciation, amortization of intangible assets associated with acquisitions, stock-based compensation expense, and adjustment to the fair value of contingent consideration. Adjusted non-GAAP net income excludes the impact of tax affected amortization of intangible assets associated with acquisitions, stock-based compensation expense, adjustment to the fair value of contingent consideration, and non-cash interest expense on convertible senior notes.

 

   
MEDIDATA SOLUTIONS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(Amounts in thousands, except per share data)
June 30, 2014 December 31, 2013
ASSETS
Current assets:
Cash and cash equivalents $ 35,192 $ 22,328
Marketable securities 183,000 218,892
Accounts receivable, net of allowance for doubtful accounts of $1,231 and $1,055, respectively 61,971 45,534
Prepaid commission expense 3,495 3,615
Prepaid expenses and other current assets 14,440 13,511
Deferred income taxes 669   665  
Total current assets 298,767 304,545
Restricted cash 5,118 5,118
Furniture, fixtures and equipment, net 41,237 41,229
Marketable securities, long-term 200,283 195,105
Goodwill 15,655 15,487
Intangible assets, net 650 904
Deferred income taxes, long-term 356 345
Other assets 9,161   10,620  
Total assets $ 571,227   $ 573,353  
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 5,283 $ 7,524
Accrued payroll and other compensation 10,654 27,773
Accrued expenses and other 9,686 12,265
Deferred revenue 57,909   52,628  
Total current liabilities 83,532   100,190  
Noncurrent liabilities:
Convertible 1.00% senior notes, net 235,228 229,705
Deferred revenue, less current portion 440 1,430
Deferred tax liabilities 2,588 5,651
Other long-term liabilities 15,205   10,564  
Total noncurrent liabilities 253,461   247,350  
Total liabilities 336,993   347,540  
Commitments and contingencies
Stockholders' equity:
Preferred stock, par value $0.01 per share; 5,000 shares authorized, none issued and outstanding
Common stock, par value $0.01 per share; 100,000 shares authorized, 55,817 and 55,018 shares issued; 54,002 and 53,634 shares outstanding, respectively 558 550
Additional paid-in capital 273,664 248,336
Treasury stock, 1,815 and 1,384 shares, respectively (44,513 ) (26,414 )
Accumulated other comprehensive income (loss) 504 (199 )
Retained earnings 4,021   3,540  
Total stockholders' equity 234,234   225,813  
Total liabilities and stockholders' equity $ 571,227   $ 573,353  
 

 
MEDIDATA SOLUTIONS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(Amounts in thousands)
Six Months Ended June 30,
2014   2013
Cash flows from operating activities:
Net income $ 481 $ 10,806
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 5,144 3,324
Stock-based compensation 18,329 12,329
Amortization of discounts or premiums on marketable securities 2,714 1,001
Deferred income taxes (3,146 ) 3,883
Amortization of debt issuance costs 639 30
Amortization of debt discount 5,523
Excess tax benefit associated with equity awards (2,648 ) (997 )
Contingent consideration adjustment 120
Provision for doubtful accounts 266 657
Changes in operating assets and liabilities:
Accounts receivable (18,328 ) 3,274
Prepaid commission expense 657 (830 )
Prepaid expenses and other current assets 1,018 1,153
Other assets 87 (78 )
Accounts payable 2,476 (900 )
Accrued payroll and other compensation (7,134 ) (2,338 )
Accrued expenses and other 5,437 1,183
Deferred revenue 3,588 (4,140 )
Other long-term liabilities 2,711   591  
Net cash provided by operating activities 17,814   29,068  
Cash flows from investing activities:
Purchase of furniture, fixtures and equipment (11,602 ) (6,761 )
Purchase of available-for-sale marketable securities (113,019 ) (78,255 )
Proceeds from sale of available-for-sale marketable securities 141,214 65,272
Net decrease in restricted cash 226   388  
Net cash provided by (used in) investing activities 16,819   (19,356 )
Cash flows from financing activities:
Proceeds from exercise of stock options 1,885 6,150
Proceeds from employee stock purchase plan 2,513
Excess tax benefit associated with equity awards 2,648 997
Payment of acquisition-related earn-out (704 ) (380 )
Repayment of obligations under capital leases (39 ) (27 )
Acquisition of treasury stock (28,058 ) (10,461 )
Repayment of notes payable (85 ) (38 )
Net cash used in financing activities (21,840 ) (3,759 )
Net increase in cash and cash equivalents 12,793 5,953
Effect of exchange rate changes on cash and cash equivalents 71 (76 )
Cash and cash equivalents - Beginning of period 22,328   32,683  
Cash and cash equivalents - End of period $ 35,192   $ 38,560  
 

More Stories By Business Wire

Copyright © 2009 Business Wire. All rights reserved. Republication or redistribution of Business Wire content is expressly prohibited without the prior written consent of Business Wire. Business Wire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
To get the most out of their data, successful companies are not focusing on queries and data lakes, they are actively integrating analytics into their operations with a data-first application development approach. Real-time adjustments to improve revenues, reduce costs, or mitigate risk rely on applications that minimize latency on a variety of data sources. In his session at @BigDataExpo, Jack Norris, Senior Vice President, Data and Applications at MapR Technologies, reviewed best practices to ...
A strange thing is happening along the way to the Internet of Things, namely far too many devices to work with and manage. It has become clear that we'll need much higher efficiency user experiences that can allow us to more easily and scalably work with the thousands of devices that will soon be in each of our lives. Enter the conversational interface revolution, combining bots we can literally talk with, gesture to, and even direct with our thoughts, with embedded artificial intelligence, whic...
Cloud Expo | DXWorld Expo have announced the conference tracks for Cloud Expo 2018. Cloud Expo will be held June 5-7, 2018, at the Javits Center in New York City, and November 6-8, 2018, at the Santa Clara Convention Center, Santa Clara, CA. Digital Transformation (DX) is a major focus with the introduction of DX Expo within the program. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive ov...
Continuous Delivery makes it possible to exploit findings of cognitive psychology and neuroscience to increase the productivity and happiness of our teams. In his session at 22nd Cloud Expo | DXWorld Expo, Daniel Jones, CTO of EngineerBetter, will answer: How can we improve willpower and decrease technical debt? Is the present bias real? How can we turn it to our advantage? Can you increase a team’s effective IQ? How do DevOps & Product Teams increase empathy, and what impact does empath...
DevOps promotes continuous improvement through a culture of collaboration. But in real terms, how do you: Integrate activities across diverse teams and services? Make objective decisions with system-wide visibility? Use feedback loops to enable learning and improvement? With technology insights and real-world examples, in his general session at @DevOpsSummit, at 21st Cloud Expo, Andi Mann, Chief Technology Advocate at Splunk, explored how leading organizations use data-driven DevOps to close th...
As many know, the first generation of Cloud Management Platform (CMP) solutions were designed for managing virtual infrastructure (IaaS) and traditional applications. But that's no longer enough to satisfy evolving and complex business requirements. In his session at 21st Cloud Expo, Scott Davis, Embotics CTO, explored how next-generation CMPs ensure organizations can manage cloud-native and microservice-based application architectures, while also facilitating agile DevOps methodology. He expla...
Smart cities have the potential to change our lives at so many levels for citizens: less pollution, reduced parking obstacles, better health, education and more energy savings. Real-time data streaming and the Internet of Things (IoT) possess the power to turn this vision into a reality. However, most organizations today are building their data infrastructure to focus solely on addressing immediate business needs vs. a platform capable of quickly adapting emerging technologies to address future ...
Most technology leaders, contemporary and from the hardware era, are reshaping their businesses to do software. They hope to capture value from emerging technologies such as IoT, SDN, and AI. Ultimately, irrespective of the vertical, it is about deriving value from independent software applications participating in an ecosystem as one comprehensive solution. In his session at @ThingsExpo, Kausik Sridhar, founder and CTO of Pulzze Systems, discussed how given the magnitude of today's application ...
With tough new regulations coming to Europe on data privacy in May 2018, Calligo will explain why in reality the effect is global and transforms how you consider critical data. EU GDPR fundamentally rewrites the rules for cloud, Big Data and IoT. In his session at 21st Cloud Expo, Adam Ryan, Vice President and General Manager EMEA at Calligo, examined the regulations and provided insight on how it affects technology, challenges the established rules and will usher in new levels of diligence arou...
There is a huge demand for responsive, real-time mobile and web experiences, but current architectural patterns do not easily accommodate applications that respond to events in real time. Common solutions using message queues or HTTP long-polling quickly lead to resiliency, scalability and development velocity challenges. In his session at 21st Cloud Expo, Ryland Degnan, a Senior Software Engineer on the Netflix Edge Platform team, will discuss how by leveraging a reactive stream-based protocol,...
Mobile device usage has increased exponentially during the past several years, as consumers rely on handhelds for everything from news and weather to banking and purchases. What can we expect in the next few years? The way in which we interact with our devices will fundamentally change, as businesses leverage Artificial Intelligence. We already see this taking shape as businesses leverage AI for cost savings and customer responsiveness. This trend will continue, as AI is used for more sophistica...
In his session at 21st Cloud Expo, Raju Shreewastava, founder of Big Data Trunk, provided a fun and simple way to introduce Machine Leaning to anyone and everyone. He solved a machine learning problem and demonstrated an easy way to be able to do machine learning without even coding. Raju Shreewastava is the founder of Big Data Trunk (www.BigDataTrunk.com), a Big Data Training and consulting firm with offices in the United States. He previously led the data warehouse/business intelligence and B...
In his general session at 21st Cloud Expo, Greg Dumas, Calligo’s Vice President and G.M. of US operations, discussed the new Global Data Protection Regulation and how Calligo can help business stay compliant in digitally globalized world. Greg Dumas is Calligo's Vice President and G.M. of US operations. Calligo is an established service provider that provides an innovative platform for trusted cloud solutions. Calligo’s customers are typically most concerned about GDPR compliance, application p...
Digital transformation is about embracing digital technologies into a company's culture to better connect with its customers, automate processes, create better tools, enter new markets, etc. Such a transformation requires continuous orchestration across teams and an environment based on open collaboration and daily experiments. In his session at 21st Cloud Expo, Alex Casalboni, Technical (Cloud) Evangelist at Cloud Academy, explored and discussed the most urgent unsolved challenges to achieve f...
"Digital transformation - what we knew about it in the past has been redefined. Automation is going to play such a huge role in that because the culture, the technology, and the business operations are being shifted now," stated Brian Boeggeman, VP of Alliances & Partnerships at Ayehu, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.